Model
Edge
Alnylam Pharmaceuticals, Inc.
0001708764
Filing type
4
Filing date
Feb 4, 2024
Updated
Feb 5, 2024 ยท 9:05 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership